GFAP and Alzheimer disease: However, researchers have to be cautious with retrospective analyzes: We measured CSF GFAP (SIMOA) in n = 62 AD patients (samples from 2008 to 2021) and found a strong correlation with sample age (lower levels in older samples, data not shown).